Eloxx Pharmaceuticals, Inc. (ELOX)

19.02 -0.97 (-4.85%) USD  |  OTCM  |  Aug 25, 15:04
More

Eloxx Pharmaceuticals Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ELOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2026. Start Trial.
Date Value
August 20, 2026 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Filana Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Cannabis Global, Inc. --
Breakthrough Chemistry, Inc. --
BioStem Technologies, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade